10
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Stimulation of endogenous cyclic AMP levels in ciliary body by SK&F 82526, a novel dopamine receptor agonist

, &
Pages 449-456 | Received 27 Mar 1986, Accepted 05 May 1986, Published online: 02 Jul 2009

References

  • Sears M. L. Autonomic nervous system: adrenergic agonists. Handbook of Experimental Pharmacology, M. L. Sears. Springer‐Verlag, Berlin 1984; Vol. 69: 193–248
  • Shannon R. P., Mead A., Sears M. L. The effect of dopamine on the intraocular pressure and pupil of the rabbit eye. Invest. Ophthalmol. 1976; 15: 371–380
  • Macri F. J., Cevario S. J. The inhibitory actions of dopamine, hydroxyam‐phetamine and phenylephrine on aqueous humor formation. Ex. Eye Res. 1978; 26: 85–98
  • Green K., Hensley A., Lollis G. Dopamine stimulation of passive permeability and secretion in the isolated rabbit ciliary epithelium. Exp. Eye Res. 1979; 29: 423–427
  • Green K., Elijah D. Drug effects on aqueous humor formation and psuedofacility in normal rabbit eyes. Exp. Eye Res. 1981; 33: 239–245
  • Potter D. E., Burke J. A., Chang F. W. Alteration in ocular function induced by phenylethylamine analogs of dopamine. Current Eye Res. 1984; 3: 851–859
  • Hahn R. A., Wardell J. R., Sarau M., Ridley P. T. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. J. Pharm. Ex. Therap. 1982; 223: 305–313
  • Harper J. F., Brooker G. Femto‐mole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2′0 acetylation by acetic anhydride in aqueous solution. J. Cyclic Nucletide Res. 1975; 1: 207–218
  • Steiner A. L., Parker C. H., Kipnis D. M. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J. Biol. Chem. 1972; 247: 1106–1113
  • Waitzman M. B., Woods W. D. Some characteristics of an adenyl cyclase preparation from rabbit ciliary process tissue. Exp. Eye Res. 1971; 12: 99–111
  • Neufeld A. H., Sears M. L. Cyclic AMP in ocular tissues of the rabbit, monkey and human. Invest. Ophthalmol. 1974; 13: 475–477
  • Berkowitz B. A., Zabko‐Potapovich B., Sherman S., Hieble J. P., Weinstock J., Ohlstein E. H. Vascular effects of SK&F 83566: a selective dopamine (DA‐1) receptor antagonist. Fed. Proc. 1984; 43: 743
  • Berkowitz B. A., Erickson R., Zabko‐Potapovich B., Ohlstein E. Vascular dopamine and dopamine receptor angonists. Dopamine Receptor Agonists, G. Poste, S. T. Crooke. Plenum Press, New York 1984; 195–208
  • Sears M. L. Catecholamines in relation to the eye. Handbook of Physiology, E. Artwood, R. Greep. American Physiological Society, Washington, D. C. 1975; 553–590
  • Cooper R. L., Constable I. J., Davidson L. Aqueous humor Catecholamines. Current Eye Res. 1984; 3: 809–813
  • Mekki Q. A., Hassan S. M., Turner P. Bromocriptine lowers intraocular pressure without affecting blood pressure. The Lancet, June 1983; 4: 1250–1251
  • Potter D. E., Burke J. A., Chang F. W. Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympath‐ectomy and domperidone pretreatment. Current Eye Res. 1984; 3: 307–314
  • Stone R. A., Laties A. M., Hetnmings H. C., Quimet C. C., Greengard P. DARPP‐32 in the ciliary epithelium of the eye: a neurotransmitter‐regulated phosphoprotein of brain localizes to secretory cells. J. Histochem. Cytochem. 1986, in press
  • Caprioli J., Sears M. The adenylate cyclase receptor complex and aqueous formation. Yale J. Biol. Med. 1984; 57: 283–300

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.